Skip to content

Author

O. Cornely

6 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

How do I manage candiduria: practical algorithms and remaining conundrums in 2026.

BACKGROUND Candiduria is frequently encountered in hospitalized patients and encompasses a wide spectrum of clinical scenarios, ranging from asymptomatic colonization or sample contamination to genuine urinary tract infections and, in rarer cases, invasive candidiasis. Despite its high prevalence, especially in urologi...

D. Blez, Z. Pana, A. Lampros et al. · 0 citations
Open access Sep 2026

Treatment and outcome of chronic disseminated candidiasis in the era of antifungal prophylaxis: a retrospective multicentre cohort of 111 patients

Summary Background Chronic disseminated candidiasis (CDC) is a severe manifestation of invasive candidiasis predominantly affecting patients with haematological malignancies. Treatment recommendations are based on limited observational data, and the impact of widespread antifungal prophylaxis on CDC epidemiology and ou...

I. Reinhold, I. Ramírez-Sánchez, Pao-Yu Chen et al. · 0 citations
Review Open access Sep 2026

Immunotherapy for invasive Candida infections: Translating host-directed strategies into clinical practice.

BACKGROUND Candida infections are a leading cause of invasive fungal disease (IFD), especially among critically ill and immunocompromised patients. Despite available pathogen-directed antifungal therapies, outcomes remain unsatisfactory with high associated morbidity and mortality rates. Increasing recognition of immun...

R. Sprute, Shakti Singh, Heather R. Conti et al. · 0 citations
Review Open access Oct 2026

Assessing the Willingness of Future Health Care Providers to Participate in Vaccine Trials: Cross-Sectional VACCELERATE European Study

In this multicountry European sample of health professional students, only one-third reported willingness to participate in future vaccine trials, while the largest group was unsure, suggesting that trial-readiness initiatives for future health professionals should prioritize transparent communication about safety moni...

Andreas Yiallouris, Charalampos Filippou, C. Merakou et al. · 0 citations
Open access Aug 2026

Point prevalence assessments of five respiratory viruses in adults ≥ 50 years of age in Germany by multi-pathogen rapid antigen testing on June 1, 2024, and December 15, 2024.

PURPOSE Acute respiratory infections (ARI) impose a significant burden on healthcare systems and society. This study aimed to investigate the circulation of respiratory viruses in community-dwelling older adults in Germany. METHODS Participants aged ≥ 50 years in Germany performed multi-pathogen rapid antigen self-te...

Miranda Anggitakirana, Julia A. Nacov, J. Salmanton-García et al. · 0 citations
Review Sep 2026

Multicomponent vaccination against seasonal influenza and COVID-19: a strategy to address the continued global burden of disease in adults.

Promising multicomponent influenza-COVID-19 vaccine candidates currently being evaluated in clinical trials may represent an important advancement in adult immunization strategy, and a meaningful opportunity to strengthen protection against two of the most consequential respiratory pathogens worldwide.

W. Schaffner, S. Gravenstein, S. Kissler et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.